Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Ascend Communications (ASND) -- Ignore unavailable to you. Want to Upgrade?

To: michael modeme who wrote (56920)	11/8/1998 3:04:00 AM
From: Bindusagar Reddy	Respond to of 61433

Michael, you are absoultely right on the Biotechs, especially one involved in Human genomics with applied life sciences. Leaders here are Human Genome Sciences, Incyte pharmaceuticals, Millinium pharmaceuticals. All of these are 500-750 million market cap range. These are potential 10 baggers before 2001. ASND, if they succeed in being a major #1 or #2 player in building the future information superhighway, it should be a 5 bagger conservatively from here, by year 2001. If momentum players start loving this one like DELL, it could be a 10 bagger. They will do fine by themselves, you don't need LU to acquire them, they might as well continue partnering. BR